Harrow (HROW) Net Margin (2013 - 2026)

Harrow (HROW) recorded quarterly Net Margin of 62.44% in Q1 2026, down 635.08% quarter-over-quarter from 11.67% in Q4 2025, and down 2527.0% on a YoY basis from 2.57% in Q1 2025.

Harrow (HROW) Net Margin (2013 - 2026) Analysis & Trends

Harrow's Net Margin history runs 14 years deep, the most recent figure standing at 62.44% for Q1 2026.

  • In Q1 2026, Net Margin fell 2527.0% year-over-year to 62.44%; the TTM figure through Mar 2026 stood at 4.16% (up 603.0% YoY), while the FY2025 annual figure was 1.89%, up 687.0% from the prior year.
  • Net Margin was 62.44% for Q1 2026 at Harrow, down from 11.67% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 11.67% in Q4 2025 to a low of 62.44% in Q1 2026.
  • Historically, Net Margin has averaged 15.68% across 5 years, with a median of 12.81% in 2023.
  • The sharpest annual moves came in 2022 and 2023: Net Margin surged 4193 bps in 2022, then slumped 3035 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 5.19% in 2022, then tumbled by 585 bps to 25.16% in 2023, then soared by 140 bps to 10.14% in 2024, then rose by 15 bps to 11.67% in 2025, then plunged by 635 bps to 62.44% in 2026.
  • The last three Net Margin figures came in at 62.44% (Q1 2026), 11.67% (Q4 2025), and 1.42% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 9.19%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 26.57%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 4.16%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -168.42%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 31.38%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -15.15%
10 Harrow 1.23 Bn 1.14 Bn 27.05 Mn -62.44%

Historic Data

Download Data
DateValue
Mar 31, 2026 -62.44%
Dec 31, 2025 11.67%
Sep 30, 2025 1.42%
Jun 30, 2025 7.84%
Mar 31, 2025 -37.17%
Dec 31, 2024 10.14%
Sep 30, 2024 -8.57%
Jun 30, 2024 -13.23%
Mar 31, 2024 -39.22%
Dec 31, 2023 -25.16%
Sep 30, 2023 -12.81%
Jun 30, 2023 -12.64%
Mar 31, 2023 -25.45%
Dec 31, 2022 5.19%
Sep 30, 2022 -28.32%
Jun 30, 2022 -26.75%
Mar 31, 2022 -11.02%
Dec 31, 2021 -36.74%
Sep 30, 2021 -44.51%
Jun 30, 2021 -16.27%